CVKD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: trend is firmly bearish (SMA_200 > SMA_20 > SMA_5) and MACD is negatively expanding, which typically signals further downside risk even if oversold.", "Price is sitting right on key support (S1 ~ 6.229; pre-market ~ 6.23). If that level breaks, the next support is ~5.695, leaving poor immediate reward/risk for an impatient entry.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: no signal on given stock today.\n- SwingMax: No signal on given stock recently.", "With no near-term catalyst (no news) and weak fundamental profile (no revenue; ongoing losses), the setup doesn\u2019t justify buying now."]
["Trend/structure: Bearish moving-average stack (SMA_200 > SMA_20 > SMA_5) confirms downtrend.", "Momentum: MACD histogram -0.0922 below zero and negatively expanding = bearish momentum strengthening.", "Mean-reversion: RSI_6 at 19.3 indicates deeply oversold; a short-term bounce is possible but currently not confirmed by momentum indicators.", "Key levels: Pivot 7.095 (needs reclaim to improve structure). Resistance R1 7.96, R2 8.494. Support S1 6.229 (currently being tested), then S2 5.695.", "Pattern-based probability: Similar-pattern stats suggest ~+0.73% next day, ~-0.15% next week, ~-2.95% next month, which tilts against a buy for anything beyond a very short scalp."]
near support (S1 ~6.229), which can trigger a reflex bounce if buyers defend the level.", "Net income loss improved YoY in 2025/Q3 (less negative by ~11.5%), showing some cost/expense progress."]
["No news in the recent week: no visible event-driven catalyst to reverse the downtrend.", "Bearish momentum is still accelerating (MACD histogram negatively expanding), increasing odds that support breaks.", "Weak/early-stage fundamentals: revenue remains at 0 and the business is still loss-making.", "EPS deterioration in 2025/Q3 (EPS -1.31, down ~39.9% YoY), which is negative for sentiment."]
["Latest quarter: 2025/Q3.", "Revenue: 0 (no YoY growth).", "Net income: -2,685,705 (improved ~11.5% YoY but still meaningfully negative).", "EPS: -1.31 (worsened ~39.9% YoY), implying per-share performance deteriorated.", "Overall: still pre-revenue/low-revenue profile with continued losses; not supportive of a momentum reversal without a catalyst."]
["No analyst rating or price target change data provided, so there is no confirmed recent Wall Street upgrade/downgrade trend to support a buy thesis.", "Street pros (general): would view improving losses as a minor positive; cons would focus on no revenue, EPS deterioration, and technical downtrend."]
